Lazard Asset Management’s Gabelli Healthcare & Wellness Trust GRX Stock Holding History

Lazard Asset Management’s Portfolio GRX Stock Details GRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-417,507	Closed	-$3.9M	–	2178
2023 Q4	$3.9M	Hold	417,507	–	–	﹤0.01%	731
2023 Q3	$3.58M	Sell	417,507 -1,360	-0.3%	-$13K	﹤0.01%	764
2023 Q2	$4.17M	Hold	418,867	–	–	0.01%	740
2023 Q1	$4.23M	Sell	418,867 -54,720	-12%	-$556K	0.01%	765
2022 Q4	$4.87M	Hold	473,587	–	–	0.01%	723
2022 Q3	$4.5M	Hold	473,587	–	–	0.01%	729
2022 Q2	$5.08M	Hold	473,587	–	–	0.01%	736
2022 Q1	$6.07M	Buy	473,587 +6,687	+1%	+$85.3K	0.01%	728
2021 Q4	$6.33M	Hold	466,900	–	–	0.01%	732
2021 Q3	$6.17M	Buy	466,900 +5,100	+1%	+$69.1K	0.01%	710
2021 Q2	$6.23M	Hold	461,800	–	–	0.01%	692
2021 Q1	$5.75M	Hold	461,800	–	–	0.01%	652
2020 Q4	$5.52M	Hold	461,800	–	–	0.01%	642
2020 Q3	$4.76M	Hold	461,800	–	–	0.01%	613
2020 Q2	$4.64M	Hold	461,800	–	–	0.01%	584
2020 Q1	$4M	Hold	461,800	–	–	0.01%	580
2019 Q4	$5.32M	Hold	461,800	–	–	0.01%	556
2019 Q3	$4.81M	Hold	461,800	–	–	0.01%	558
2019 Q2	$4.86M	Hold	461,800	–	–	0.01%	606
2019 Q1	$4.85M	Hold	461,800	–	–	0.01%	595
2018 Q4	$4.27M	Buy	461,800 +130,500	+39%	+$1.34M	0.01%	561
2018 Q3	$3.65M	Buy	+331,300	New	+$3.52M	0.01%	612
2016 Q3	–	Sell	-25,741	Closed	-$274K	–	1015
2016 Q2	$274K	Hold	25,741	–	–	﹤0.01%	777
2016 Q1	$253K	Sell	25,741 -10,422	-29%	-$99.7K	﹤0.01%	763
2015 Q4	$370K	Sell	36,163 -6,109	-14%	-$61.9K	﹤0.01%	748
2015 Q3	$409K	Sell	42,272 -34,400	-45%	-$375K	﹤0.01%	719
2015 Q2	$861K	Sell	76,672 -5,455	-7%	-$61.5K	﹤0.01%	709
2015 Q1	$924K	Sell	82,127 -23,122	-22%	-$250K	﹤0.01%	707
2014 Q4	$1.1M	Sell	105,249 -19,634	-16%	-$200K	﹤0.01%	751
2014 Q3	$1.24M	Buy	124,883 +32,728	+36%	+$331K	﹤0.01%	661
2014 Q2	$952K	Sell	92,155 -27,884	-23%	-$281K	﹤0.01%	718
2014 Q1	$1.2M	Sell	120,039 -9,315	-7%	-$93K	﹤0.01%	660
2013 Q4	$1.3M	Hold	129,354	–	–	﹤0.01%	682
2013 Q3	$1.24M	Buy	129,354 +29,697	+30%	+$289K	﹤0.01%	656
2013 Q2	$943K	Buy	+99,657	New	+$992K	﹤0.01%	710

Other funds holding GRX

SCM

Saba Capital Management New York $3.62B AUM 13% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

GAMCO Investors Greenwich, Connecticut $10.2B AUM 30.27% 1-Year Est. Return

Cornerstone Advisors Asheville, North Carolina $2.72B AUM 22.17% 1-Year Est. Return

Cetera Investment Advisers Schaumburg, Illinois $94B AUM 20.14% 1-Year Est. Return

Cetera Advisors Denver, Colorado $12.7B AUM 22.7% 1-Year Est. Return

AQR Arbitrage Greenwich, Connecticut $6.09B AUM 27.01% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

WAM

Wolverine Asset Management Chicago, Illinois $10.4B AUM 4.78% 1-Year Est. Return

BPA

Beacon Pointe Advisors Newport Beach, California $18.9B AUM 18.9% 1-Year Est. Return

Lazard Asset Management's GRX Position: Q1 2024 in Review

Lazard Asset Management sold out of Gabelli Healthcare & Wellness Trust (GRX) in Q1 2024, closing a stake of 417,507 shares — an estimated $3.9M sold.

Lazard Asset Management first reported a position in GRX in Q2 2013 and held it in 35 quarters. The position peaked at $6.33M in Q4 2021. 69 funds tracked by Wall St. Rank hold GRX as of Q1 2024.

Lazard Asset Management reported no remaining Gabelli Healthcare & Wellness Trust position as of Q1 2024 after selling out during the quarter.
Lazard Asset Management sold 417,507 Gabelli Healthcare & Wellness Trust shares in Q1 2024, an estimated $3.9M.
Lazard Asset Management first reported a position in Gabelli Healthcare & Wellness Trust in Q2 2013 and held it in 35 quarters.
Lazard Asset Management's Gabelli Healthcare & Wellness Trust position peaked at $6.33M in Q4 2021.
69 funds tracked by Wall St. Rank held Gabelli Healthcare & Wellness Trust as of Q1 2024.

Based on Lazard Asset Management's 13F filing for Q1 2024, filed 14 May 2024.